Some parents may struggle with managing children’s anger, poll suggests

Many parents are all too familiar with angry outbursts from their children, from sibling squabbles to protests over screen time limits.

FDA rejects higher dose of Regeneron blockbuster due to contractor issues

Regeneron said late Tuesday that the FDA rejected its new, 8-mg version of its blockbuster Eylea (aflibercept) due to an ongoing review of inspection findings

June 28, 2023

Advances in neutropenia research could pave the way for better treatments

Neutropenia is a condition in which there are not enough neutrophils, a type of white blood cell, in the blood.

November 6, 2024

Eli Lilly’s obesity drug Zepbound shows benefits in heart failure patients

Eli Lilly’s obesity drug Zepbound cut the risk of complications and improved symptoms in patients with a common type of heart failure, making it the

August 1, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.